Health Care • Biotechnology: Electromedical & Electrotherapeutic Apparatus
$26.58 ▼ -1.24
(-4.46%)
MKT CAP: $1.07B • VOL: 582.7K
52W L $11 52W H $28
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$22
MEDIAN
$30
MEAN
$30
HIGH
$36
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE CBLL TAPE
CBLL // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $32.16 | $30.57 | 2025-02-14 | $24.19 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $33.49 | $31.36 | 2025-02-06 | $24.99 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $30.30 | $29.24 | 2025-01-29 | $25.52 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $27.11 | — | 2025-01-17 | $26.05 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $23.39 | $25.25 | 2025-01-09 | $23.66 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $31.63 | $27.64 | 2024-12-18 | $23.12 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $25.78 | $26.85 | 2024-12-04 | $24.72 | -4.3% | 48% | C |